Instant
Melanoma
Risk Assessment
Powered by Multi-Agent AI
Designed for medical professionals
Detect melanoma early and save lives
Agentic AI Dermatology
For Medical Professionals
Instant Melanoma Risk Assessment
From taking an image of a mole to a complete melanoma risk assessment, Nevus AI gives your patients peace of mind in seconds.
Integrate Into Any Clinical Pathway
Nevus AI is a tablet-ready app & easy to use by nurses, doctors & dermatologists.
Ready to deploy in any clinical setting, from mobile units, pharmacists, doctor surgery, care homes & hospitals.
Triage High Risk Cases
Nevus AI can recommend high risk cases of melanoma for further investigation by a dermatologist.
Multi-Opinion Risk Assessment
For Melanoma
Multi-Agent AI Analysis
Nevus AI examines the mole using 6 independent AI agents. Replicating an entire dermatological centre.
Comprehensive Mole Examination
Nevus AI examines the mole image in various rotations, resolutions & scales to detect colour, shape, patterns & textures. Including analysing the mole in the frequency domain using Fourier Analysis.
Detecting Melanoma Features
Nevus AI agents have been trained to detect features of the mole that indicate melanoma, including asymmetry, irregular borders & multiple colours.
Clinical Interpretability Images
Nevus AI generates GradCAM++ heatmap images that highlight aspects of the mole the AI agent found clinically significant in its assessment.
How Nevus AI Works
AI Dermatology In Action
Stratified Multi-Agent System Hierarchy - SMASH
Nevus AI uses a consensus of 6 AI agents to classify a mole as either Normal (nevus) or Suspect (melanoma).
Each AI agent has been trained on 4 separate datasets of moles.
Which means the mole is examined by 24 AI models, across 7.44 billion parameters.
The confidence scores from all AI agents are combined to recommend further investigation by a dermatologist.
The Accuracy of Nevus AI
Nevus AI has been tested using mole images that have never been seen by SMASH.
The results of the test were:
Accuracy: 97.18% | Sensitivity: 97.10% | Specificity: 97.26%
Nevus AI has a Negative Predictive Value (NPV) of 99.91%
Making Nevus AI an ideal tool to eliminate melanoma or triage high risk cases, early.
Contact Us To Access
Nevus AI
Nevus AI is designed for medical professionals & ready to integrate into any clinical pathway.
Contact us for more information about our tablet-ready app: